Tradestie Institutional Equity Comparison Engine
AADR vs APVO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
APVO Overall Edge
APVO Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aptevo Therapeutics Inc (APVO) driven by superior Valuation, Growth & Margin while AADR counters with relative strength in Momentum & Technical. Fundamentally, AADR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus APVO at 3.9x Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, AADR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against APVO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
APVO
AADR N/M vs APVO 3.9x Fwd P/E
Growth & Margin Winner
APVO
Op Margin N/A vs 0.0% ยท YoY N/A vs -100.0%
Momentum & Technical Winner
AADR
1Y -9.7% vs -62.2% ยท 52W Pos 6% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AADR
NASDAQ
AdvisorShares Dorsey Wright ADR ETF
Institutional Equity
$77.92
-1.77% 1D
Market Cap
N/A
1M Return
-2.99%
1Y Return
-9.72%
Forward P/E
N/M
Unified AI Score
57.7 / 100
HOLD
Tech 73.0
Fund 59.0
Flow 50.0
Mom 60.0
APVO
NASDAQ
Aptevo Therapeutics Inc
Pharmaceutical Preparations
$0.55
-7.68% 1D
Market Cap
$1.4M
1M Return
-66.14%
1Y Return
-62.17%
Forward P/E
3.9x
Unified AI Score
36.9 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AADR -9.72%
APVO -62.17%
Spread: +54.29 pp (AADR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AADR TTM Op. Margin: N/A
APVO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AADR vs APVO. Trailing 12-month operating profitability (AADR N/A vs APVO 0.0%) and valuation multiples (AADR N/M vs APVO 3.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AADR | APVO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.4M | Larger Scale | APVO |
| Trailing P/E Ratio Valuation | N/M | 0.0x | Lower Multiple | APVO |
| Forward P/E Ratio Valuation | N/M | 3.9x | Lower Multiple | APVO |
| Revenue Growth (YoY) Growth | N/A | -100.0% | Higher Growth | APVO |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | APVO |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | APVO |
| Return on Equity (ROE) Capital Efficiency | N/A | -420.3% | Higher ROE | APVO |
| 52-Week Range Position Momentum | 6% ($77โ$98) | 0% ($0โ$11) | Stronger Trend | AADR |
| Beta / 30D Volatility Risk Regime | 1.12ฮฒ ยท 23% Vol | 0.29ฮฒ ยท 122% Vol | Lower Realized Risk | AADR |
| Unified Institutional Score Composite Signal | 57.7 / 100 (HOLD) | 36.9 / 100 (SELL) | Higher Composite | AADR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AADR vs APVO Buy Guide
AADR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
APVO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AADR nor APVO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.